Pfizer weighs next AstraZeneca move


NEW YORK, NY - MAY 05: People walk past the Pfizer logo on their world headquarters in Manhattan on May 5, 2014 in New York City. Pfizer, the Global pharmaceutical company, reported Monday that total first-quarter revenue fell 9 percent to $11.35 billion, a 9% drop over the prior-year period. Spencer Platt/Getty Images/AFP== FOR NEWSPAPERS, INTERNET, TELCOS & TELEVISION USE ONLY ==

LONDON: US drugmaker Pfizer fought back against criticism that its planned takeover of rival AstraZeneca would damage Britain’s science base by saying strong UK research was a key reason for the deal.

Given its record of big job cuts after past acquisitions, the US group has come under fire in Britain, the United States and Sweden as it weighs its next move to buy AstraZeneca.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , pfizer

   

Next In Business News

Chin Hin taps Ajiya for two-year RM250mil loan
MI Technovation posts three-fold surge in net profit
CIMB Securities eyes larger market share
InNature diversifies into the F&B industry
Yinson’s RM16bil debt too big to ignore
Leap in operating income for UOB’s retail banking
Paramount emerges as major shareholder in EWI
New capacity in the pipeline
March industrial production index up 2.4%, but below forecast
Data centre – boon or bane?

Others Also Read